Ladder Health has closed an oversubscribed $7 million seed financing round to expand a virtual-first, AI-assisted therapy platform for children with developmental delays. The company's model is built around a straightforward premise: clinics cannot keep pace with demand, and families are paying the price in time.

The shortfall is well documented. One in four children under six are considered at risk of a developmental delay, whether in speech, movement, feeding or behaviour. Paediatricians widely regard the first five years as the period when intervention does the most good, when a child's brain is most responsive to therapy and most likely to recover ground quickly. Yet families seeking help often wait more than six months for a first appointment. Workforce shortages have left many regions without enough qualified therapists, and the gap is worse for rural households and those relying on Medicaid, where provider networks are thinner and travel distances longer.

Ladder Health offers speech, occupational, physical and feeding therapy entirely online, scheduling sessions in the evenings and at weekends so that working parents are not forced to take time off or pull children out of school. The company says this alone removes one of the more mundane but persistent barriers to consistent care, since missed sessions due to clashing schedules are common in traditional clinic settings.

The more distinctive part of the model is its treatment of parents as active participants rather than bystanders. Rather than confining progress to a weekly clinical visit, therapists coach parents to carry out exercises and techniques between sessions, with AI tools tracking a child's responses and adjusting home activities accordingly. The company argues that this extends therapeutic contact well beyond the limited minutes a child might otherwise spend with a specialist each week, and that consistent practice at home is often what determines whether early intervention actually works.

The round was led by Nina Capital and was oversubscribed, a sign that investors see room for growth in a sector where digital health has often focused on adult chronic disease rather than paediatric development. Ladder Health plans to use the funding to expand across North Carolina, Massachusetts and Maryland, three states chosen partly for their mix of urban and rural populations and partly for existing relationships with regional health systems. The company intends to deepen those partnerships further, alongside continued investment in the AI systems that underpin its remote monitoring and treatment planning.

Mitch Mudra, the company's chief executive, said the case for early intervention has never been in doubt among clinicians, but that the system built to deliver it has fallen short of what families need. He pointed to the months-long waits many parents face as evidence that good intentions are not enough without the capacity to act on them quickly, particularly for families who cannot afford private care or simply wait out a long queue. According to Mudra, the test of any new model is not whether it works in principle but whether it reaches the families who have historically been failed by the existing system, including those on lower incomes and those living far from specialist clinics.

The funding arrives at a moment when paediatric therapy waitlists have become a recurring concern among US health policymakers, particularly as schools and paediatricians report rising referral numbers for speech and developmental delays following widespread disruption to early years services in recent years. Whether virtual-first models such as Ladder Health's can absorb that demand at scale remains to be tested, but the company's early backers are betting that a faster, more flexible alternative to the traditional clinic queue has a meaningful market ahead of it.

‍